Health ❯Obesity

Treatment Options

Drug Efficacy Weight Loss Dieting Reproductive Rights Patents Diabetes Treatment Weight Management Insulin Products Type 2 Diabetes Addiction

Novo Nordisk Launches Wegovy in India to Counter Lilly’s Mounjaro as CagriSema Falls Short

The launch precedes semaglutide’s patent expiry in early 2026.

Bariatric Surgery Surpasses GLP-1 Drugs in Real-World Weight Loss

Former Weight Watchers Leader Nears Weight Goal After Mounjaro Success

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

UK to Trial Pharmacy-Based NHS Weight-Loss Jab Prescriptions

UK Nears One Million Users of Weight-Loss Jabs as New Benefits and Risks Emerge

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

Novo Nordisk Reports Doubling Wegovy Sales, Projects Slower Growth in 2025